Filters

Anti-PMS1 (Polyclonal), ALEXA Fluor 594

Anti-PMS1 (Polyclonal), ALEXA Fluor 594 size: 100 microliters 489

Price 489
Size 100 microliters
TypeConjugated Primary Antibody
Conjugated with 594, ALEXA FLUOR®
Host organismRabbit (Oryctolagus cuniculus)
Target Protein/PeptidePMS1
SpecificityThis antibody reacts specifically with PMS1
ModificationNo modification has been applied to this antibody
Modification siteNone
ClonalityPolyclonal Antibody
ClonePolyclonal Antibodies
Concentration1ug per 1ul
Subcellular locationsN/A
Antigen SourceKLH conjugated synthetic peptide derived from human PMS1
Gene ID5378
Swiss ProtN/A
ApplicationsIF(IHC-P)
Applications with corresponding dilutionsIF(IHC-P)(1:50-200)
Cross reactive species Mouse (Mus musculus), Rat (Rattus norvegicus), Human (Homo sapiens)
Cross Reactive Species details However, note that due to limited knowledge it is impossible to predict with 100% guarantee that the antibody does not corss react with any other species, No significant cross reactivity has been observed for this antibody for the tested species
Background information Initially, The demonstration that 10 to 45% of pancreatic, Two additional homologs of the prokaryotic MutL gene, breast, designated PMS1 and PMS2, gastric, have been identified and shown to be mutated in the germline of HNPCC patients, inherited mutations in the MSH2 and MLH1 homologs of the bacterial DNA mismatch repair genes MutS and MutL were demonstrated at high frequency in HNPCC and were shown to be associated with microsatellite instability, ovarian and small cell lung cancers also display microsatellite instability has been interpreted to suggest that DNA mismatch repair is not restricted to HNPCC tumors but is a common feature in tumor initiation or progression, The finding that mutations in DNA mismatch repair genes are associated with hereditary nonpolyposis colorectal cancer (HNPCC) has resulted in considerable interest in the understanding of the mechanism of DNA mismatch repair
Purification methodPurified by Protein A
Storage 50% glycerol and 0, Store at 4°, 09% sodium azide, C for 12 months, Water buffered solution containing 100ug/ml BSA
Excitation emission590nm/617nm
Synonyms MLH2
Also known asPMS1 Polyclonal Antibody
Other nameAnti-PMS1 Polyclonal
Advisory For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, specificity and sensitivity, thus reducing its reactivity, Avoid freeze/thaw cycles as they may denaturate the polypeptide chains of the antibody
PropertiesFor facs or microscopy Alexa 1 conjugate
ConjugationAlexa Fluor
GroupPolyclonals and antibodies
About The advantage is that there are more epitopes available in a polyclonal antiserum to detect the proteins than in monoclonal sera, immunohistochemistry on frozen slices or parrafin fixed tissues, Polyclonals can be used for Western blot
Gene targetPMS1
Short nameAnti-PMS1 (Polyclonal) Fluor 594
Technique Pabs are a collection of immunoglobulin , Polyclonal antibodies , each identifying a different , whereas , (pAbs) are mostly rabbit or goat , B cells, Polyclonal, antibodies , antigen, come from a single N cell lineage, epitope, molecules that react against a specific , monoclonal antibodies , that are secreted by different 
LabelALEXA
Alternative name ALEXA Fluor 594, antibody to-PMS1 (polyclonal)
Alternative techniquepolyclonals
Identity 9121
Gene PMS1
Long gene name PMS1 homolog 1, mismatch repair system component
Synonyms gene PMSL1
Synonyms gene name cerevisiae) , cerevisiae) 1 PMS1 postmeiotic segregation increased 1 (S, postmeiotic segregation increased (S
Locus 2q32, 2
Discovery year 1994-12-13
Entrez gene record 5378
Pubmed identfication 8072530 23608172
RefSeq identity NM_000534
Classification MutL homologs
Havana BLAST/BLAT OTTHUMG00000132664
Locus Specific Databases HNPCC Colon cancer gene variant databases PMS1 database at LOVD-China LRG_221 , Hereditary Non-Polyposis Colorectal Cancer

Subscribe to our Newsletter